JANX

Janux Therapeutics, Inc. - Common Stock (JANX)

About Janux Therapeutics, Inc. - Common Stock (JANX)

Janux Therapeutics, Inc. operates a preclinical stage biopharmaceutical company which engages in developing therapeutics based on the Tumor Activated T Cell Engager platform technology. The company was founded by David Campbell in June 2017 and is headquartered in San Diego, CA.

Details

Daily high

$17.14

Daily low

$16.57

Price at open

$16.86

52 Week High

$35.34

52 Week Low

$12.12

Market cap

1.0B

Dividend yield

Volume

94,100

Avg. volume

1.0M

P/E ratio

-10.09

Janux Therapeutics, Inc. - Common Stock News